RhumbLine Advisers’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $816K | Sell |
|
|||||
|
2025
Q2 | $1.42M | Buy |
|
|||||
|
2025
Q1 | $878K | Buy |
|
|||||
|
2024
Q4 | $687K | Buy |
|
|||||
|
2024
Q3 | $918K | Sell |
|
|||||
|
2024
Q2 | $561K | Buy |
|
|||||
|
2024
Q1 | $379K | Buy |
|
|||||
|
2023
Q4 | $199K | Sell |
|
|||||
|
2023
Q3 | $137K | Buy |
|
|||||
|
2023
Q2 | $231K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $85K | Buy |
|
|||||
|
2021
Q4 | $141K | Buy |
|
|||||
|
2021
Q3 | $200K | Buy |
|
|||||
|
2021
Q2 | $515K | Buy |
|
|||||
|
2021
Q1 | $575K | Buy |
|